| |
We explain what types of agency meetings can be sought in the EU, US, Japan, China, and Canada, and provide details to guide requesting and preparing for agency interactions. Learn more. 
|
|
Today’s Big NewsAug 10, 2023 |
| By Nick Paul Taylor Novo Nordisk is keeping its foot on the gas as it strives to carve out a strong position in the exploding obesity market, inking a deal worth up to $1.1 billion to buy a biotech that is dusting off an old approach to triggering weight loss. |
|
|
|
| Philadelphia, PA |  |
|
|
By Annalee Armstrong And just like that, we have a crowded race to be the first approved NASH treatment—a market that could grow to $108.4 billion globally by 2030. |
By James Waldron Galera Therapeutics has slammed the emergency button in the wake of a complete response letter from the FDA for a radiotherapy complication drug, jettisoning 70% of its employees as the biotech’s stock sinks. |
By Nick Paul Taylor Inovio is making its third round of layoffs in 13 months. Facing a long path to approval, the biotech has stopped its cervical lesion program to focus on its most promising, closest-to-market programs, putting 58 people out of work in the process. |
By Gabrielle Masson Part of EQRx’s implosion earlier this year included cutting ties with China-based Lynk Pharmaceuticals. However, Lynk seems to have safely removed itself from EQRx’s wreckage, as its eczema asset improved area and severity in a phase 2 clinical trial. |
By Max Bayer Some six months removed from laying off a quarter of its staff, Surrozen has once again found itself in cash preservation mode, culling two research programs to save money. |
By Gabrielle Masson American Gene Technologies (AGT) may be a little bit dizzy with all this spinning. The biotech has inked a blank-check deal for subsidiary Addimmune, signing off the HIV-focused unit to special purpose acquisition company 10X Capital Venture Acquisition Corp. III. |
By Helen Floersh Scientists and clinicians studying COVID-19 have long suspected that the disease doesn’t just affect the lungs, but many other organ systems too. Now, researchers have identified a mechanism that could explain why and reveal new pathways to find treatments for long COVID. |
By Angus Liu Johnson & Johnson is digging its multiple myeloma moat deeper. The FDA has signed off on the company's Talvey, a first-in-class bispecific antibody targeting GPRC5D. |
By Andrea Park Kim Kardashian took to Instagram on Tuesday to boost the (already high) profile of scanning service provider Prenuvo. |
By Nick Paul Taylor The self-regulatory body of the German communications industry has accused BioNTech of trying to pull out of a public debate about vaccine patents. BioNTech received the warning after it asked Twitter to “hide” its account ahead of an online campaign that targeted developers of COVID-19 vaccines in 2020. |
By Dave Muoio A new analysis of hospitals' posted prices finds major differences in charged prices by plan, even when the hospital, insurer and service are all equivalent. |
By Conor Hale Glympse Bio, developer of an injectable diagnostic platform, has been acquired by Sunbird Bio, which plans to point the companies’ resources toward a new blood test for Alzheimer’s disease. |
Fierce podcasts Don’t miss an episode |
| This week on "Podnosis," we take a closer look at intersectionality and a group that has been ignored: intersex individuals. |
|
|---|
|
|
Whitepaper Learn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Thermo Fisher Scientific Process Liquid Preparation Services |
Whitepaper In oncology, traditional methods for determining sales force size & structure are no longer appropriate. This paper describes the multiple drivers of sales strategy in oncology markets today. Sponsored by: Blue Matter, strategic consultants in the life sciences |
Research Learn how the right chemical inventory strategy helped save a mid-size CDMO millions of dollars while securing a stable supply of products with just-in-time delivery. Sponsored by: Thermo Fisher Scientific Production Chemicals and Services |
Whitepaper Learn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
Webinar Download this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
Whitepaper Learn more about the current challenges and issues that eClinical technology providers are facing. Sponsored by: YPrime |
| |
|
